More frequent side effects include: cataract.
See below for a comprehensive list of adverse effects.
As well as its needed effects, eltrombopag (the active ingredient contained in Promacta) may cause unwanted side effects that require medical attention.
Some eltrombopag side effects may not need any medical attention.
As your body gets used to the medicine these side effects may disappear.
Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
The most common side effects reported in ITP patients have included nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, and rash.
The most common side effects reported in thrombocytopenic patients with chronic hepatitis C have included anemia, pyrexia, fatigue, headache, nausea, diarrhea, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, myalgia, alopecia, and peripheral edema.
Common ( to ): Deep vein thrombosis, edema, palpitations, peripheral edema, prolonged QT interval on ECG, thrombotic/thromboembolic eventsUncommon ( to ): Acute myocardial infarction, cardiovascular disorder, chest pain, cyanosis, embolism, flushing, hematoma, hot flush, hypertension, sinus tachycardia, superficial thrombophlebitis, tachycardia
Common ( to ): Abnormal hepatic function, ascites, hepatic failure, hyperbilirubinemia, increased ALT or AST, increased blood alkaline phosphatase, increased blood bilirubin levels, jaundice, portal vein thrombosis, drug-induced liver injuryUncommon ( to ): Cholestasis, hepatic lesion, hepatitis
In clinical trials, hepatic decompensation (ascites, hepatic encephalopathy, variceal hemorrhage, spontaneous bacterial peritonitis) was reported more commonly in chronic HCV patients with cirrhosis treated with eltrombopag compared to placebo.
Very common ( or more): AnemiaCommon ( to ): Decreased hemoglobin, decreased neutrophil count, decreased white blood cell count, hemolytic anemia, increased INR, lymphopenia, prolonged activated partial thromboplastin time Uncommon ( to ): Anisocytosis, eosinophilia, increased hemoglobin, increased band neutrophil count, increased platelet cell counts, leukocytosis, myelocytosis, presence of myelocytes, thrombocytopenia
In clinical studies, hemorrhage was the most common serious adverse reaction and most hemorrhagic reactions followed discontinuation of eltrombopag.
Very common ( or more): Diarrhea, nauseaCommon ( to ): Abdominal discomfort, abdominal distension, abdominal pain, aphthous stomatitis, constipation, dry mouth, dyspepsia, dysgeusia, esophageal varices hemorrhage, esophageal varices, gastritis, gastroenteritis,stomatitis, gastroesophageal reflux disease, hemorrhoids, toothache, upper abdominal pain, vomitingUncommon ( to ): Abdominal tenderness, discolored feces, flatulence, food poisoning, frequent bowel movements, gingival bleeding, glossodynia, hematemesis, hemorrhoids, mouth hemorrhage, oral discomfort
Very common ( or more): Alopecia, pruritusCommon ( to ): Dry skin, eczema, erythema, generalized pruritus, hyperhidrosis, night sweats, pruritic rash, rash, skin lesionUncommon ( to ): Cold sweat, contusion, dermatosis, ecchymosis, inflammation of wound, melanosis, petechia, pigmentation disorder, skin discoloration, skin exfoliation, swelling face, sunburn, urticaria
Common ( to ): Urinary tract infectionUncommon ( to ): Dysuria, leukocyturia, nocturia, proteinuria
Uncommon ( to ): Hypersensitivity
Very common ( or more): Influenza-like illnessCommon ( to ): Influenza, oral herpes
Very common ( or more): Decreased appetiteCommon ( to ): Abnormal loss of weight, decreased blood albumin, hyperglycemia, increased blood glucoseUncommon ( to ): Gout, hypocalcemia, hypokalemia, increased appetite, increased blood albumin, increased blood uric acid, increased total protein, increased weight
Very common ( or more): MyalgiaCommon ( to ): Arthralgia, back pain, bone pain, muscle spasm, musculoskeletal pain, pain in extremityUncommon ( to ): Muscular weakness, sensation of heaviness
Very common ( or more): HeadacheCommon ( to ): Dizziness, hepatic encephalopathy, lethargy, memory impairment, paresthesiaUncommon ( to ): Balance disorder, cerebral infarction, dysesthesia, hemiparesis, hypoesthesia, migraine, migraine with aura, peripheral neuropathy, peripheral sensory neuropathy, somnolence, speech disorder, toxic neuropathy, tremor, vascular headache
Common ( to ): Cataract, dry eye, ocular icterus, retinal exudates, retinal hemorrhageUncommon ( to ): Abnormal visual acuity tests, astigmatism, blepharitis, blurred vision, conjunctival hemorrhage, cortical cataract, eye pain, increased lacrimation, keratoconjunctivitis sicca, lenticular opacities, retinal hemorrhage, retinal pigment epitheliopathy, reduced visual acuity, visual impairment,
Common ( to ): Malignant hepatic neoplasmUncommon ( to ): Rectosigmoid cancer
Very common ( or more): InsomniaCommon ( to ): Agitation, anxiety, confusional state, depression, disturbance in attention, sleep disorderUncommon ( to ): Altered mood, apathy, tearfulness
Uncommon ( to ): Increased blood creatinine, increased blood urea, increased urine pH, increased urine protein/creatinine ratio, lupus nephritis, renal failure
Very common ( or more): Cough (up to ), upper respiratory tract infection (up to ), nasopharyngitis (up to ), rhinorrhea (up to )Common ( to ): Bronchitis, dyspnea, exertional dyspnea, oropharyngeal pain, pharyngitis, productive cough, pulmonary embolism, upper respiratory tract infection, rhinitis, oropharyngeal painUncommon ( to ): Epistaxis, nasal discomfort, oropharyngeal blistering, pneumonia, pulmonary infarction, sinusitis, sinus disorder, sleep apnea syndrome, tonsillitis
Very common ( or more): Asthenia, chills, fatigue, pyrexiaCommon ( to ): Chest discomfort, irritability, malaise, non-cardiac chest pain, painUncommon ( to ): Ear pain, feeling hot, feeling jittery, ill-defined disorder, mucosal inflammation, pyrexia, sensation of foreign body, vertigo, vessel puncture site hemorrhage
Common ( to ): Injection site rash/pruritus, injection site reaction
It is possible that some side effects of Promacta may not have been reported.
These can be reported to the FDA here.
Always consult a healthcare professional for medical advice.
Bloating or swelling of the face, arms, hands, lower legs, or feet
body aches or pain
chills or fever
cough
difficulty with breathing
headache
loss of voice
pale skin
rapid weight gain
runny nose
sore throat
tingling of the hands or feet
troubled breathing with exertion
unusual tiredness or weakness
unusual weight gain or loss
yellow eyes or skin
Bladder pain
blindness
blurred or decreased vision
bruising
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
diarrhea
general feeling of discomfort or illness
hoarseness
joint pain
lower back or side pain
muscle aches and pains
nausea
pinpoint red spots on the skin
redness of the eye
shivering
sweating
tender, swollen glands in the neck
trouble sleeping
trouble swallowing
voice changes
vomiting
Chest pain
pain, redness, or swelling in the legs or arms
Decreased appetite
difficulty with moving
hair loss or thinning of the hair
itching skin
lack or loss of strength
muscle aching or cramping
muscle pains or stiffness
swollen joints
Acid or sour stomach
back pain
belching
bone pain
dry mouth
heartburn
indigestion
rash
stomach discomfort, upset, or pain